Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations [Phase 1, Phase 2]
This clinical trial investigates whether adding valemetostat tosylate to pembrolizumab improves outcomes compared with pembrolizumab alone i…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of radiation therapy with a DLL3-targeting bispecific T-cell engager in DLL3-expres…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]
Update on a Phase 1/2 trial evaluating pembrolizumab with stereotactic body radiation therapy or wide-field radiation therapy in patients wi…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Evaluating the Feasibility and Preliminary Effects of BE+ [NA]
A clinical trial update on BE+ evaluating feasibility and preliminary effects in non-small cell lung cancer, focusing on self-management beh…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer [Phase 1, Phase 2]
Clinical trial update on AZD7789 evaluating safety and efficacy in participants with advanced or metastatic solid cancers in Phase 1/2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study [NA]
The RAD-AI study seeks to use artificial intelligence-directed dose planning for stereotactic body radiation therapy in patients with primar…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of intratumoral MVR-T3011 given alone or with pembrolizumab in adults with advanced o…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
This clinical trial update describes a study evaluating detection of tumor cells and tumor DNA in blood, urine, and bone marrow across multi…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X) [Phase 2]
Phase 2 trial evaluates whether radiation given before a tyrosine kinase inhibitor delays progression in advanced driver-mutated non-small c…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy
A clinical trial investigating whether microbiome analysis can predict treatment response and toxicity after concurrent chemoradiotherapy in…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with BDB001 and immunogenic radiotherapy for advanced solid tumors is currentl…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation. [Phase 2]
Phase 2 study evaluating JBI-802 alone or in combination with pembrolizumab for non-small cell lung cancer with an STK11 mutation; currently…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of adding a short course of a MEK inhibitor to chemoimmunotherapy…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating infusion of NY-ESO-1–specific TCR-engineered lymphocytes in patients with NY-ESO-1-expressing…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Study With Various Immunotherapy Treatments in Participants With Lung Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of various immunotherapy treatments for advanced non-small cell lung cancer, sponsored …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Intrathecal Double Checkpoint Inhibition [Phase 1]
This Phase 1 clinical trial from the University of Zurich investigates intrathecal double checkpoint inhibition for leptomeningeal metastasi…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: DC/NK Cell Therapy [Phase 2]
Phase 2 clinical trial investigating DC/NK cell therapy for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: The IVO-LUNG Study [Phase 2]
The IVO-LUNG Study is a Phase 2 clinical trial for Non-Small Cell Lung Cancer (Stage III) that is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study [NA]
A randomized trial evaluating circulating DNA to improve outcomes in oncology is currently recruiting for colorectal cancer and non-small ce…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD [NA]
This ClinicalTrials.gov listing describes an ongoing trial investigating adaptive therapy for patients with resected stage I A2 to II non-sm…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients [Phase 1]
This is a Phase 1 clinical trial update evaluating APG-1252 in combination with osimertinib for EGFR TKI-resistant non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations [Phase 2]
A Phase 2 clinical trial update investigating the first-line use of amivantamab, lazertinib, and pemetrexed in recurrent/metastatic EGFR-mut…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer. [Phase 2]
Phase II trial update for QL1706 combined with platinum-based chemotherapy in SMARCA4-deficient locally advanced or metastatic non-small cel…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung
A clinical trial registry entry describing a pragmatic analysis of complex radiotherapy cases in lung cancer (non-small cell and small cell)…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET [Phase 1]
Phase 1 study of TPX-0022 in patients with advanced MET-altered solid tumors, including non-small cell lung cancer and gastric cancer; the t…